Literature DB >> 19703261

Probiotic microbes: do they need to be alive to be beneficial?

Jasmeet Kataria1, Nan Li, James L Wynn, Josef Neu.   

Abstract

An essential symbiotic relationship exists between intestinal cells and commensal bacteria within the human gastrointestinal tract. Alteration or absence of this interaction may play a role in the development of human disease. Use of probiotic organisms has yielded improvement of certain medical conditions, such as inflammatory and infectious gastrointestinal disease, although the mechanisms of benefit remain poorly defined. The administration of live organisms is not without risk, both potential and realized, particularly in certain populations. Therefore, it is of considerable interest to determine if the health benefits of probiotics can be attained without the risks associated with administration of a live organism. Reviewed here is the evidence that heat-killed, ultraviolet-inactivated, and even components of these agents may be just as effective and considerably safer for the host.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19703261     DOI: 10.1111/j.1753-4887.2009.00226.x

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  36 in total

1.  The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept).

Authors:  Valentina Taverniti; Simone Guglielmetti
Journal:  Genes Nutr       Date:  2011-04-16       Impact factor: 5.523

Review 2.  Probiotics and necrotizing enterocolitis.

Authors:  Josef Neu
Journal:  Clin Perinatol       Date:  2014-09-30       Impact factor: 3.430

3.  The probiotic Lactobacillus plantarum counteracts TNF-{alpha}-induced downregulation of SMCT1 expression and function.

Authors:  Alip Borthakur; Arivarasu N Anbazhagan; Anoop Kumar; Geetu Raheja; Varsha Singh; Krishnamurthy Ramaswamy; Pradeep K Dudeja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-29       Impact factor: 4.052

4.  Microbial lysate upregulates host oxytocin.

Authors:  Bernard J Varian; Theofilos Poutahidis; Brett T DiBenedictis; Tatiana Levkovich; Yassin Ibrahim; Eliska Didyk; Lana Shikhman; Harry K Cheung; Alexandros Hardas; Catherine E Ricciardi; Kumaran Kolandaivelu; Alexa H Veenema; Eric J Alm; Susan E Erdman
Journal:  Brain Behav Immun       Date:  2016-11-05       Impact factor: 7.217

5.  Immunomodulation of monocytes by probiotic and selected lactic Acid bacteria.

Authors:  Hanne Jensen; Signe Marie Drømtorp; Lars Axelsson; Stine Grimmer
Journal:  Probiotics Antimicrob Proteins       Date:  2015-03       Impact factor: 4.609

Review 6.  Evidence-based guidelines for use of probiotics in preterm neonates.

Authors:  Girish C Deshpande; Shripada C Rao; Anthony D Keil; Sanjay K Patole
Journal:  BMC Med       Date:  2011-08-02       Impact factor: 8.775

7.  Comparative Analysis of Antigiardial Potential of Heat Inactivated and Probiotic Protein of Probiotic Lactobacillus rhamnosus GG in Murine Giardiasis.

Authors:  Geeta Shukla; Shweta Kamboj; Bhawna Sharma
Journal:  Probiotics Antimicrob Proteins       Date:  2020-03       Impact factor: 4.609

8.  Protection against increased intestinal permeability and bacterial translocation induced by intestinal obstruction in mice treated with viable and heat-killed Saccharomyces boulardii.

Authors:  Simone V Generoso; Mirelle L Viana; Rosana G Santos; Rosa M E Arantes; Flaviano S Martins; Jacques R Nicoli; José A N Machado; Maria Isabel T D Correia; Valbert N Cardoso
Journal:  Eur J Nutr       Date:  2010-10-10       Impact factor: 5.614

9.  Oral intake of Lactobacillus pentosus strain b240 accelerates salivary immunoglobulin A secretion in the elderly: A randomized, placebo-controlled, double-blind trial.

Authors:  Yoshifumi Kotani; Shoji Shinkai; Hiroshi Okamatsu; Masamichi Toba; Kishiko Ogawa; Hiroto Yoshida; Taro Fukaya; Yoshinori Fujiwara; Paulo Hm Chaves; Keiji Kakumoto; Noriyuki Kohda
Journal:  Immun Ageing       Date:  2010-08-26       Impact factor: 6.400

10.  Microbial cell components induced tolerance to flagellin-stimulated inflammation through Toll-like receptor pathways in intestinal epithelial cells.

Authors:  Nan Li; Maria C Quidgley; Firas H Kobeissy; Jessica Joseph; Josef Neu
Journal:  Cytokine       Date:  2012-09-01       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.